Scott Myers
Board Member
Zentalis Pharmaceuticals, Inc. (ZNTL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Scott Myers
Scott Myers is recorded as Chairman and Board Member at Zentalis Pharmaceuticals, Inc. (ZNTL). Zentalis Pharmaceuticals, Inc. reported in an 8-K filed November 13, 2024 that Scott Myers was appointed Class II director, effective November 13, 2024. Zentalis Pharmaceuticals, Inc. reported in an 8-K filed November 13, 2024 that Scott Myers was appointed Chairperson of the Board, effective November 13, 2024.
“On November 12, 2024, the Board appointed Scott Myers as a Class II director and Chairperson of the Board, effective on the Transition Date.”
“On November 12, 2024, the Board appointed Scott Myers as a Class II director and Chairperson of the Board, effective on the Transition Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-11-13–present
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Zentalis Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Julie Eastland CEO, Board Member
- Kimberly Blackwell, M.D. CEO
- David M. Johnson Chairman
- Cam Gallagher CFO
- Vincent Vultaggio CFO, Chief Accounting Officer
- Iris Roth COO
- Iris Roth, Ph.D. COO
- James B. Bucher General Counsel
- David Johnson Board Member
- Enoch Kariuki Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.